GLP-1 Weight Loss Review
Hers GLP-1 Weight Loss Review 2026: FDA-Approved Wegovy, Not Compounded
Almost every GLP-1 telehealth platform we review dispenses compounded semaglutide. Hers does not — it prescribes FDA-approved Wegovy, the branded semaglutide made by Novo Nordisk, as a daily pill or a once-weekly pen.
- FDA-approved Wegovy, not compounded
- Daily pill or weekly pen
- No insurance required
- Cancel anytime
Prescription required — a licensed clinician determines eligibility after online intake
By Charly P. · Published July 31, 2026 · 10 min read
- FDA-approved brand-name Wegovy
- Licensed U.S. clinicians
- 100% online intake
- No long-term contract
Hers costs roughly double the cheapest compounded programs on our list — the question is whether what you are paying extra for is something you actually need.
About Hers: What Makes It Different
Hers is the women's telehealth brand of Hims & Hers Health, a publicly traded company operating direct-to-consumer prescription care since 2017. Its weight loss program is built around brand-name Wegovy, supported by a care team that handles dose escalation and check-ins.
| Wegovy (Hers) | A finished drug product reviewed by the FDA for safety, efficacy, and manufacturing quality; made in FDA-registered facilities. |
|---|---|
| Compounded semaglutide | Prepared to order by a licensed compounding pharmacy under state pharmacy board oversight — same active molecule, but the finished preparation is not individually FDA-evaluated. |
Both routes are legal; they carry different regulatory guarantees.
How We Scored Hers
How We Scored It
FDA-approved brand-name Wegovy — the only pilot review in our comparison set that is not a compounded preparation.
Both a daily oral pill and a weekly injectable pen are offered — most competitors offer only one format.
Personalized care team with ongoing dose check-ins throughout titration.
Roughly double the cost of the cheapest compounded programs, though priced at parity with other brand/near-brand competitors.
100% online intake, no insurance required, no long-term contract.
Scores reflect our editorial assessment of Hers's published program as of July 2026, not a clinical rating.
Hers Pricing 2026
Hers prices the two Wegovy formats separately. Both are self-pay rates that include the clinical review and ongoing care team support.
Wegovy pricing by format
| Format | Price | Dosing |
|---|---|---|
| Wegovy Pill (oral) | $149/month | Daily |
| Wegovy Injectable Pen | $199/month | Weekly |
How that compares
| Provider | Semaglutide From | Medication Type |
|---|---|---|
| Hers | $149/mo (pill) | FDA-approved Wegovy |
| Embody | $69/mo | Compounded |
| altRx | $89/mo | Compounded |
| TrimRx | $149/mo | Compounded |
| Yucca Health | $146/mo | Compounded |
The comparison that actually matters is the bottom half of that table, not the top. Against TrimRx ($149/mo) and Yucca Health ($146/mo), Hers is priced at parity while supplying a brand-name product rather than a compounded one — arguably the better value in that band. Only against the $69–89 tier does the premium become a real trade-off.
How Hers Works
- 1.Complete the online intake
Answer questions covering your weight history, medical background, and current medications. No in-person appointment and no insurance details required.
- 2.Clinician review
A licensed clinician reviews your submission, determines eligibility, and recommends a format, the daily oral pill or the once-weekly injectable pen.
- 3.Medication ships to you
If approved, brand-name Wegovy is shipped to your home. Because it is an FDA-approved finished product, it arrives in manufacturer packaging rather than a compounded preparation.
- 4.Ongoing dose check-ins
Your care team monitors tolerability through the titration schedule and adjusts dosing over time, which is where most GLP-1 side effects are managed.
Pros and Cons
Pros
- FDA-approved brand-name Wegovy, not a compounded preparation
- Both formats available: daily oral pill and weekly injectable pen
- Oral option removes the injection entirely for needle-averse patients
- Personalized care team with ongoing dose check-ins included
- No insurance required and no long-term contract
- Backed by a publicly traded telehealth operator with a long trading history
- Priced at parity with several compounded programs in the $146–149 band
Cons
- Roughly double the cost of the cheapest compounded programs
- No compounded or generic alternative offered as a lower-cost tier
- No tirzepatide option, semaglutide only
- Does not bill insurance, so the full cost is out of pocket
- Brand-name supply is subject to manufacturer availability in a way compounded supply is not
Who Hers Is For
Hers makes sense for a specific patient: someone who has decided an FDA-approved finished product is non-negotiable and is willing to pay for that certainty — patients uneasy about compounding oversight, patients whose clinicians advised brand-name only, and patients who want a daily pill instead of a weekly injection.
It is the wrong choice if cost is your binding constraint: at $149/month you are paying more than twice what Embody charges for the same active molecule, compounded. It is also the wrong choice if you want tirzepatide, which Hers does not offer.
Hers Alternatives
Looking for alternatives to Hers? Here are the top-rated GLP-1 weight loss programs we recommend:
- Directmeds: leads with 50% off the first month but discloses the ongoing price during intake rather than publishing it upfront — worth resolving before you commit to either.
- Pallas Health: a clinician chooses between a brand-name pen and a per-patient preparation, rather than the platform deciding for you.
- Maximus: breaks down semaglutide and tirzepatide pricing separately.
Recommended Providers
Our editorial team’s top picks for this category.
Frequently Asked Questions
Bottom Line
Our Editorial Take
Hers is the clearest expression of a trade-off the rest of this category tries to blur: you can have the FDA-approved product or you can have the low price, and Hers has picked the first without apology. Framed against $69 compounded semaglutide, $149 looks like a steep premium. Framed against TrimRx and Yucca Health, which charge about the same for a compounded preparation, Hers looks like the better-specified option at the same price.
A daily Wegovy pill at $149/month is a genuinely different product from a weekly injection, and for anyone whose real barrier to GLP-1 therapy has been the needle rather than the cost, it is the reason to look here first. Tirzepatide is absent entirely, so anyone wanting the dual GIP/GLP-1 molecule needs to shop elsewhere, such as altRx. Overall: 9.8/10.
Caveat: brand-name GLP-1 supply depends on manufacturer availability. Confirm current stock and pricing directly with Hers before committing.
Safety and Regulatory Context
According to the FDA, semaglutide is approved for chronic weight management under specific clinical criteria, and the agency has published guidance distinguishing compounded semaglutide from the approved finished products. Hers dispenses the approved product, which is the basis of its positioning.
The CDC reports that roughly 40% of U.S. adults have obesity, which is the demand backdrop against which both brand-name and compounded GLP-1 telehealth has expanded so quickly.
Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.